• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA XIST 通过与 TET1 结合下调 p53 参与膀胱癌的发生。

Long noncoding RNA XIST participates in bladder cancer by downregulating p53 via binding to TET1.

机构信息

Department of Urology, The Fifth People's Hospital of Shanghai, Fudan University, Shanghai, China.

Department of Urology, Huai'an Second People's Hospital and The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.

出版信息

J Cell Biochem. 2019 Apr;120(4):6330-6338. doi: 10.1002/jcb.27920. Epub 2018 Oct 25.

DOI:10.1002/jcb.27920
PMID:30362292
Abstract

Long noncoding RNAs (lncRNAs) have been reported to take part in intracellular RNA regulatory networks and play important roles in a lot of pathological processes. Currently, lncRNA X-inactive specific transcript (XIST) has been proved to regulate cell migration, proliferation, and apoptosis in a series of cancers. In this study, we explored whether XIST can affect cell proliferation, migration, and apoptosis in bladder cancer. The influences of XIST on the cell proliferation, cell cycle, and apoptosis were detected in bladder cancer cells. The effect of XIST on the migration of bladder cancer cells was examined by cell migration assay. Through RNA immunoprecipitation and chromatin immunoprecipitation assays, the binding relationship between XIST and TET1 and the regulatory mechanism of TET1 on p53 were examined. Western blot was performed to detect p53 after knockdown or overexpression of XIST. We found that knockdown of XIST suppressed cell migration and proliferation in vitro. Mechanistically, we confirmed that lncRNA XIST participates in bladder cancer by downregulating p53 via binding to TET1. In conclusion, our research revealed the potential role of XIST-TET1-p53 regulatory network in bladder cancer.

摘要

长链非编码 RNA(lncRNA)已被报道参与细胞内 RNA 调控网络,并在许多病理过程中发挥重要作用。目前,X 失活特异性转录本(XIST)已被证明可调节一系列癌症中的细胞迁移、增殖和凋亡。在本研究中,我们探讨了 XIST 是否可以影响膀胱癌中的细胞增殖、迁移和凋亡。通过检测 XIST 对膀胱癌细胞增殖、细胞周期和凋亡的影响,研究了 XIST 对膀胱癌细胞迁移的影响。通过 RNA 免疫沉淀和染色质免疫沉淀实验,检测了 XIST 与 TET1 的结合关系以及 TET1 对 p53 的调控机制。通过 Western blot 检测 XIST 敲低或过表达后 p53 的表达。我们发现,XIST 敲低抑制了体外细胞的迁移和增殖。从机制上讲,我们通过证实 lncRNA XIST 通过与 TET1 结合来下调 p53,从而参与膀胱癌的发生。总之,我们的研究揭示了 XIST-TET1-p53 调控网络在膀胱癌中的潜在作用。

相似文献

1
Long noncoding RNA XIST participates in bladder cancer by downregulating p53 via binding to TET1.长链非编码 RNA XIST 通过与 TET1 结合下调 p53 参与膀胱癌的发生。
J Cell Biochem. 2019 Apr;120(4):6330-6338. doi: 10.1002/jcb.27920. Epub 2018 Oct 25.
2
The Long Non-Coding RNA XIST Interacted with MiR-124 to Modulate Bladder Cancer Growth, Invasion and Migration by Targeting Androgen Receptor (AR).长链非编码RNA XIST通过靶向雄激素受体(AR)与miR-124相互作用,调节膀胱癌的生长、侵袭和迁移。
Cell Physiol Biochem. 2017;43(1):405-418. doi: 10.1159/000480419. Epub 2017 Aug 31.
3
Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.远志酸 D(PD)通过调控 LncRNA-XIST/miR-335 轴抑制膀胱癌的体内外进展。
Exp Cell Res. 2020 Nov 1;396(1):112281. doi: 10.1016/j.yexcr.2020.112281. Epub 2020 Sep 10.
4
Long noncoding RNA ATB participates in the development of renal cell carcinoma by downregulating p53 via binding to DNMT1.长链非编码 RNA ATB 通过与 DNMT1 结合下调 p53 参与肾细胞癌的发生。
J Cell Physiol. 2019 Aug;234(8):12910-12917. doi: 10.1002/jcp.27957. Epub 2018 Dec 8.
5
LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.LncRNA XIST 敲低通过 XIST/miRNA-148a-3p/ADAM17 通路在体外和体内抑制人鼻咽癌的恶性转化。
Biomed Pharmacother. 2020 Jan;121:109620. doi: 10.1016/j.biopha.2019.109620. Epub 2019 Nov 20.
6
Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis.长非编码 RNA LOC572558 通过调节 AKT-MDM2-p53 信号轴抑制膀胱癌细胞增殖和肿瘤生长。
Cancer Lett. 2016 Oct 1;380(2):369-374. doi: 10.1016/j.canlet.2016.04.030. Epub 2016 Apr 26.
7
Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.长链非编码RNA XIST通过表观遗传抑制KLF2表达在非小细胞肺癌中发挥癌基因作用。
Biochem Biophys Res Commun. 2016 Sep 16;478(2):811-7. doi: 10.1016/j.bbrc.2016.08.030. Epub 2016 Aug 5.
8
Knockdown of long non-coding RNA linc00511 suppresses proliferation and promotes apoptosis of bladder cancer cells via suppressing Wnt/β-catenin signaling pathway.长链非编码 RNA linc00511 的敲低通过抑制 Wnt/β-连环蛋白信号通路抑制膀胱癌细胞的增殖并促进其凋亡。
Biosci Rep. 2018 Aug 29;38(4). doi: 10.1042/BSR20171701. Print 2018 Aug 31.
9
Targeting XIST induced apoptosis of human osteosarcoma cells by activation of NF-kB/PUMA signal.通过激活 NF-κB/PUMA 信号靶向 XIST 诱导人骨肉瘤细胞凋亡。
Bioengineered. 2019 Dec;10(1):261-270. doi: 10.1080/21655979.2019.1631104.
10
lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP.lncRNA XIST 通过靶向 iASPP 与 miR-140 相互作用调节肺癌生长。
Oncol Rep. 2017 Aug;38(2):941-948. doi: 10.3892/or.2017.5751. Epub 2017 Jun 26.

引用本文的文献

1
The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies.DNA甲基化与去甲基化在膀胱癌中的作用:聚焦治疗策略
Front Oncol. 2025 Jun 26;15:1567242. doi: 10.3389/fonc.2025.1567242. eCollection 2025.
2
TET1: The epigenetic architect of clinical disease progression.TET1:临床疾病进展的表观遗传构建者。
Genes Dis. 2025 Jan 4;12(5):101513. doi: 10.1016/j.gendis.2025.101513. eCollection 2025 Sep.
3
Establishment of a m6 A-associated lncRNAs-derived risk model for enhanced patient prognosis stratification and personalized therapy approaches in bladder cancer.
建立一种基于m6A相关长链非编码RNA的风险模型,以加强膀胱癌患者预后分层和个性化治疗方法。
Discov Oncol. 2025 May 22;16(1):856. doi: 10.1007/s12672-025-02646-5.
4
The role of the LncRNA XIST/miR-15a-5p/MN1 signaling axis in gender disparities in bladder cancer prognosis.长链非编码RNA XIST/微小RNA-15a-5p/MN1信号轴在膀胱癌预后性别差异中的作用
Front Immunol. 2025 Apr 16;16:1554829. doi: 10.3389/fimmu.2025.1554829. eCollection 2025.
5
Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer-From Early Detection to Prognosis.表观遗传生物标志物作为膀胱癌的新型诊断工具——从早期检测到预后
J Clin Med. 2024 Nov 26;13(23):7159. doi: 10.3390/jcm13237159.
6
Bladder cancer: non-coding RNAs and exosomal non-coding RNAs.膀胱癌:非编码 RNA 和外泌体非编码 RNA。
Funct Integr Genomics. 2024 Aug 31;24(5):147. doi: 10.1007/s10142-024-01433-9.
7
Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells.lncRNA-XIST/miRNAs/mRNAs 在人类癌细胞中的潜在作用。
Clin Transl Oncol. 2023 Jul;25(7):2015-2042. doi: 10.1007/s12094-023-03110-y. Epub 2023 Feb 28.
8
The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer.小核仁RNA(snoRNA)和长链非编码RNA(lincRNA)在膀胱癌中的诊断和治疗作用
Cancers (Basel). 2023 Feb 4;15(4):1007. doi: 10.3390/cancers15041007.
9
Long noncoding RNA : Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities.长链非编码RNA:X染色体失活机制、在性别偏向性疾病中的作用及治疗机会
Genes Dis. 2022 Apr 29;9(6):1478-1492. doi: 10.1016/j.gendis.2022.04.007. eCollection 2022 Nov.
10
The role of lncRNAs and in oral cancer.长链非编码RNA在口腔癌中的作用。 你提供的原文中“and”后面似乎缺少内容,请你检查一下是否完整,以便我能更准确地翻译。
Front Cell Dev Biol. 2022 Aug 10;10:826650. doi: 10.3389/fcell.2022.826650. eCollection 2022.